NCT05536362

Brief Summary

The Study Showed that combining clonidine and ketamine together can increase the likelihood of achieving a sufficient level of anaesthesia while minimizing post-operative discomfort and inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 10, 2022

Completed
Last Updated

October 26, 2022

Status Verified

October 1, 2022

Enrollment Period

11 months

First QC Date

September 7, 2022

Last Update Submit

October 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of Post-operative Pain

    Assessment of the pain post-operatively in Pediatric patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain, measured in millimetres from the left end bar to the mark placed by the kid on the 10 cm line anchored by happy faces (no pain) to sad faces (severe pain).

    24-hour analgesic after surgery

Study Arms (2)

TCI propofol mixed with clonidine and ketamine

EXPERIMENTAL

Patient group,in which they got intravenous anaesthesia with TCI propofol mixed with clonidine and ketamine

Drug: TCI Propofol Injection

TCI propofol mixed with a placebo

EXPERIMENTAL

Control group,in which they received intravenous anaesthesia with TCI propofol mixed with a placebo (NaCl 0.9%)

Drug: TCI Propofol Injection

Interventions

To decrease postoperative pain after cancer colon surgery

Also known as: Ketamine and clonidine
TCI propofol mixed with a placeboTCI propofol mixed with clonidine and ketamine

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA physical status I and II
  • Patients with cancer colon

You may not qualify if:

  • participants with a history of heart, renal and liver cell failure.
  • allergic reaction to studied drugs, and history of epilepsy,
  • hydrodynamic instability,
  • chronic pain.
  • mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October 6 University Hospital

Giza, Cairo Governorate, 11311, Egypt

Location

MeSH Terms

Conditions

Colonic NeoplasmsPain, Postoperative

Interventions

KetamineClonidine

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsImidazolinesImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Nirvana Elshalakany, Professor

    Department of Anesthesia and I.C.U. faculty of Medicine October six university, Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: preserving hemodynamic stability, dropping post-operative pain, and dipping morphine intake
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2022

First Posted

September 10, 2022

Study Start

February 1, 2021

Primary Completion

January 1, 2022

Study Completion

February 28, 2022

Last Updated

October 26, 2022

Record last verified: 2022-10

Locations